The review, conducted by researchers working at the intersection of biomedical engineering and endocrinology, synthesizes evidence from physiology, clinical studies, and computational modeling to answer a deceptively simple question: what hormonal processes underlie the sex-specific impact on glucose regulation, and can modern diabetes care continue to overlook physiological differences between the sexes without compromising precision and equity? The authors argue that the answer to the second question is increasingly no, particularly as automated insulin delivery systems become the standard of care and their algorithms remain calibrated to a sex-neutral, hormonally static patient.

The physiological backdrop is well established. Across an approximately 28-day cycle, estradiol and progesterone oscillate in patterns that modulate thermoregulation, energy expenditure, substrate utilization, and insulin sensitivity. Studies in healthy women show that these endocrine fluctuations influence glucose kinetics, gastric emptying, incretin secretion, and even exercise performance in a phase-dependent manner. Estradiol tends to enhance insulin-mediated glucose uptake and lipid oxidation, whereas progesterone induces relative insulin resistance and increases hepatic glucose output. The cyclic interplay between these hormones generates measurable variation in glycemia and metabolic efficiency throughout the cycle.

In women with type 1 diabetes, even modest hormonal fluctuations can produce clinically meaningful changes in insulin sensitivity and glycemic control. Yet the clinical literature is inconsistent. Some studies report increased insulin resistance or higher glucose levels during the luteal phase, when progesterone dominates; others observe minimal or no systematic phase-related effects; and interindividual variability frequently exceeds the average effect size. The review attributes these discrepancies to methodological heterogeneity, differing definitions of cycle phases, and the confounding influence of physical activity, stress, diet, and sleep, factors that are difficult to control in real-world settings but that interact directly with hormonal and metabolic pathways.

The complexity deepens considerably in the context of polycystic ovary-like metabolic dysfunction, which the review reports reaches a pooled prevalence of nearly 25 percent among women with type 1 diabetes. Here the pathophysiology is driven primarily by chronic exposure to supraphysiological peripheral insulin levels rather than classical insulin resistance. Exogenous hyperinsulinemia stimulates ovarian theca cell steroidogenesis and suppresses hepatic production of sex hormone–binding globulin, raising circulating androgens. Elevated androgens then impair insulin sensitivity through tissue-specific mechanisms: in skeletal muscle they disrupt post-receptor signaling, including IRS-1/PI3K/Akt activation and GLUT4 translocation; in adipose tissue they promote visceral fat accumulation, enhanced lipolysis, and increased free fatty acid flux. The result is a vicious cycle in which exogenous insulin excess drives ovarian hyperandrogenism, which further deteriorates insulin sensitivity and amplifies long-term cardiometabolic risk.

Against this physiological landscape, the review evaluates the state of mathematical modeling. Physiological models—computational representations built on differential equations describing hormone secretion, glucose–insulin kinetics, and metabolic fluxes—are the foundation of in silico simulators used to test insulin dosing algorithms and closed-loop control strategies before clinical deployment. The field’s canonical frameworks, from the Bergman Minimal Model of 1981 and Sorensen’s comprehensive physiological model of 1985 through the Hovorka and Dalla Man models and the widely adopted UVA/Padova simulator, have achieved remarkable methodological maturity and clinical validation. But the review finds that virtually all of these frameworks rely on sex-neutral assumptions and do not incorporate the cyclical effects of estradiol and progesterone on insulin sensitivity, glucose uptake, or hepatic glucose production.

The authors systematically classified 25 unique studies into categories spanning sex-specific physiological models of energy metabolism, machine learning approaches to menstrual phase detection from wearable data, deep learning frameworks for glucose forecasting in type 1 diabetes, and mechanistic models of the hypothalamic–pituitary–ovarian axis. Notable contributions include Fischer and Röblitz’s mechanistic model of the ovarian cycle describing estradiol, luteinizing hormone, follicle-stimulating hormone, and progesterone dynamics, validated in women undergoing in vitro fertilization, and machine learning frameworks that identify menstrual phases from heart rate, temperature, and sleep metrics with high accuracy. Yet only a handful of studies attempt to couple ovarian hormone dynamics directly to glucose regulation, and fewer still in a diabetes-specific context.

Three recent frameworks emerge as the most significant attempts to bridge the divide, and the review provides a detailed comparative analysis of their abstraction levels. Manrique-Córdoba and colleagues modify a single parameter governing peripheral insulin action within the oral glucose minimal model, representing the cycle implicitly through cycle day; the approach preserves interpretability but cannot distinguish the mechanistic contributions of individual hormones. Díaz and colleagues take a control-oriented approach, discretizing the cycle into follicular and luteal phases and translating insulin sensitivity variability, derived from euglycemic clamp data, into phase-dependent adjustments of basal rate, carbohydrate ratio, and correction factor—an approach directly relevant to automated insulin delivery but agnostic to underlying endocrine mechanisms. Ramírez offers the most mechanistically integrated strategy, coupling a phenomenological ovulatory cycle model with a minimal glucose–insulin–beta-cell system in which estradiol and progesterone are dynamic state variables modulating insulin sensitivity, insulin secretion, and beta-cell mass through saturating nonlinear functions, though the model remains exploratory and unvalidated in diabetic populations.

The review’s central conclusion is that no existing framework simultaneously provides hormonal explicitness, clinical validation in type 1 diabetes populations, and direct applicability to closed-loop insulin delivery. Current automated insulin delivery algorithms do not incorporate explicit hormonal modeling, and phase-adaptive control has not been clinically validated as a strategy to improve glycemic outcomes across the menstrual cycle. Clinical studies of automated insulin delivery across cycle phases have yielded mixed results, with some reporting no statistically significant differences in overall glycemic outcomes and others noting contrasts in time in range, underscoring the need for larger, better-controlled investigations.

The authors emphasize that hormonal fluctuations alone cannot fully explain the variability observed in glycemic responses across menstrual phases. Lifestyle factors, behavioral routines, psychosocial context, ethnicity, geographical environment, and emotional state all contribute and warrant further investigation. Nevertheless, the path forward is clear: clinically validated, control-oriented frameworks capable of identifying, tracking, and integrating ovarian hormonal dynamics into insulin delivery algorithms are needed to advance truly personalized diabetes care for women. By mapping the field’s achievements and its gaps, this review provides both a foundation and a roadmap for the next generation of sex-specific, hormone-aware diabetes technology.

Subject of Research: Mathematical modeling of ovarian hormone effects on glucose–insulin regulation in type 1 diabetes

Article Title: Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes

Article References: Albaladejo‐Carrasco, N., Furió‐Novejarque, C., Nattero‐Chávez, L., Bondia, J., & Díez, J.-L. (2026). Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes. Bioengineering & Translational Medicine, Article e70168. https://doi.org/10.1002/btm2.70168

Image Credits: AI Generated

DOI: 10.1002/btm2.70168

Keywords: type 1 diabetes, menstrual cycle, ovarian hormones, estradiol, progesterone, insulin sensitivity, glucose regulation, mathematical modeling, automated insulin delivery, closed-loop systems, hyperandrogenism, sex-specific medicine

The study drew on data from 314 families participating in a randomized controlled trial focused on the transition to parenthood. Families were recruited in Delaware, Maryland, Pennsylvania, and Texas while expecting their first child together, and were visited at home at roughly 10 months, 24 months, and seven years postpartum. At 10 months, fathers and mothers completed well-validated questionnaires measuring parenting stress, using the 27-item Parenting Stress Index, and parental self-efficacy, using items from the Parenting Sense of Competence Scale. At 24 months, both parents reported on the quality of their coparenting relationship—how well they coordinated, supported, and communicated about raising their child—using the Coparenting Relationship Scale. When children were around seven years old, researchers measured height, weight, and waist circumference, and collected small capillary blood samples via finger stick to determine glycated hemoglobin, or HbA1c, a reliable indicator of long-term blood glucose control.

The analytical approach was deliberately rigorous. The team used structural equation modeling with full information maximum likelihood estimation to handle missing data, and bias-corrected bootstrapping to test indirect, or mediated, pathways. All models adjusted for child gender, parental education, family income, and intervention group status, ensuring that the associations of interest were not simply artifacts of socioeconomic advantage or the trial itself. Model fit statistics were strong across the primary analyses, lending confidence to the pattern of results.

The headline finding concerns mothers. Greater parenting stress reported by mothers at 10 months predicted lower coparenting quality at 24 months—not only in mothers’ own eyes, but also as perceived by fathers. Lower mother-reported coparenting quality, in turn, was associated with higher child HbA1c and higher body mass index at age seven. Critically, the statistical models showed significant indirect effects: maternal stress during infancy predicted elevated child HbA1c and BMI years later through its corrosive effect on the coparenting relationship. Conversely, maternal self-efficacy in infancy predicted better coparenting quality, which was linked to lower child HbA1c, with a significant indirect pathway running from maternal confidence through coparenting to the child’s glycemic control. When maternal stress and efficacy were entered into the same model simultaneously, stress remained the dominant predictor, suggesting that mothers’ felt strain in the parenting role may be the more potent force shaping family dynamics.

The story for fathers was notably different. Paternal stress and self-efficacy were associated with fathers’ own perceptions of coparenting quality, but these paternal variables showed no significant pathways to children’s metabolic outcomes. The authors suggest several explanations. During infancy, mothers typically shoulder a larger share of day-to-day caregiving, so maternal stress may ripple more visibly through the household and into both partners’ perceptions of the coparenting relationship. Fathers, by contrast, may internalize distress or withdraw rather than express it in ways that partners perceive, consistent with prior research on paternal stress responses. The study’s authors caution that the asymmetry does not mean fathers are unimportant—it may instead reflect measurement limitations, gendered patterns of emotional expression, or the particular developmental window studied, and they call for continued research that more fully captures fathers’ roles.

Why would the quality of a coparenting alliance in toddlerhood matter for a seven-year-old’s blood glucose and body weight? The researchers outline two interlocking mechanisms grounded in the biopsychosocial model of child health. The first involves chronic stress physiology. Children embedded in low-conflict, coordinated caregiving environments experience less frequent activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Prolonged elevation of stress hormones such as cortisol is known to promote insulin resistance and central fat deposition, so a harmonious family climate may buffer children’s neuroendocrine systems from cumulative wear. The second mechanism is behavioral: when parents work as a team, they are more likely to maintain consistent routines around meals, sleep, screen time, and physical activity. Prior studies have linked higher coparenting quality to greater agreement on child feeding practices and more stable household structure, both of which are associated with healthier weight trajectories. Inconsistent limit-setting or undermined routines, common in conflicted coparenting, may fragment the regularity that developing metabolic systems depend on.

The study situates itself within family systems theory and the Determinants of Parenting framework, both of which hold that families function as interconnected units in which strain in one subsystem spills over into others. From this perspective, a stressed mother with diminished confidence may have less emotional bandwidth for supportive collaboration with her partner, and the resulting friction or inconsistency in the coparenting alliance becomes a stress-inducing feature of the child’s environment. The findings dovetail with a growing literature showing that interparental conflict is associated with heightened cardiovascular reactivity and skin conductance in children, more frequent health complaints, and—in intervention research—reduced inflammatory markers years after parenting programs improve family functioning. The new study extends this work by focusing on a much younger age window and by linking relational processes to objectively measured metabolic biomarkers rather than parent-reported health.

Not every result aligned with expectations. Mother-reported coparenting quality was associated with child BMI and HbA1c but not with waist circumference, a measure of central adiposity. The authors suggest that in younger school-aged children, age- and sex-adjusted BMI percentile may be a more sensitive screening indicator, while waist circumference may become more informative later in development. They also acknowledge important limitations. Parenting stress was assessed at a single time point, precluding analysis of within-family fluctuations; metabolic outcomes were measured only at age seven, so developmental change could not be modeled; potential mediators such as child diet, sleep, and physical activity were not directly assessed; and the sample was predominantly White, well-educated, middle-class, and largely cohabiting, limiting generalizability. Moderate attrition across seven years is an additional constraint, although retention analyses revealed few meaningful differences between families who remained and those who did not.

Even with those caveats, the implications are striking. The study did not find direct effects of early parenting stress or confidence on children’s metabolic health; instead, the coparenting relationship operated as the bridge. That suggests a concrete and testable lever for prevention: interventions that strengthen how new parents work together—programs that improve communication, mutual support, and coordination around the demands of a new baby—may pay dividends in children’s long-term physical health, not merely their emotional well-being. Existing coparenting-focused programs for first-time parents could, in principle, be evaluated for downstream metabolic benefits at little added cost. The work also reframes childhood obesity prevention, traditionally centered on diet and exercise, by highlighting the relational substrate on which healthy routines are built. As childhood obesity and type 2 diabetes rates continue to climb, evidence that the earliest family relationships help set metabolic trajectories underscores a simple but profound message: how parents care for each other may matter nearly as much as how they care for their child.

Subject of Research: Prospective associations between early parental adjustment, coparenting quality, and child metabolic health in middle childhood

Article Title: Parenting Stress, Parental Self-Efficacy, and Coparenting: Prospective Associations with Child Metabolic Health

Article References: Aytuglu, A., Graham-Engeland, J. E., Feinberg, M. E., Jones, D. E., Liu, C., & Schreier, H. M. C. (2026). Parenting Stress, Parental Self-Efficacy, and Coparenting: Prospective Associations with Child Metabolic Health. Journal of Child and Family Studies. https://doi.org/10.1007/s10826-026-03356-4

Image Credits: AI Generated

DOI: 10.1007/s10826-026-03356-4

Keywords: parenting stress, parental self-efficacy, coparenting, child metabolic health, HbA1c, childhood obesity, BMI, family systems, transition to parenthood, glucose regulation, child adiposity, longitudinal study